Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Brii Biosciences-B (02137.HK) repurchased 131,500 shares on October 27 for HK$124,000.
27/10/2026
Zhitong Finance APP News, Brii Biosciences-B (02137.HK) announced that on October 27, 2026, it spent HK$124,000 to repurchase 131,500 shares.
Latest
3 m ago
Huakai Yibai (300592.SZ) released its first three quarters performance, with net profit attributable to the parent company of 289 million yuan, a year-on-year increase of 484.45%.
3 m ago
Yoke Technology (002409.SZ) released its first three quarters results, with net profit attributable to shareholders of RMB 834 million, up 4.74% year on year.
4 m ago
Innovative New Materials (600361.SH) released its performance for the first three quarters, with net profit attributable to the parent company of 611 million yuan, a year-on-year decrease of 13.86%.
7 m ago
Ocumension Therapeutics-B (01477.HK): Fluocinolone acetonide intravitreal implant approved by the National Medical Products Administration for production in mainland China
7 m ago
Smart Control (002877.SZ) released its performance for the first three quarters, with net profit attributable to the parent company of 17.9768 million yuan, a year-on-year increase of 6.07%.
See all latest